Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study
Clinical Infectious Diseases · 16.09.2025 · 81 (2) · 263-270
DOI: 10.1093/cid/ciae645 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.03.2025. Verfasst von Alejandro G García-Ruiz de Morales und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Hauptthemen laut MEDLINE: HIV Infections, Lamivudine, Anti-HIV Agents, Tenofovir. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Although antiretroviral therapy (ART) has become less toxic over time, its long-term adverse effects remain a concern. In ART-naive people, tenofovir alafenamide (TAF) is frequently prescribed to reduce the toxicity of tenofovir disoproxil fumarate (TDF). However, the metabolic impact of TAF remains a concern. This study aimed to evaluate the metabolic effects of TAF in ART-naive participants.
Methods
We analyzed data from the Cohort of the Spanish HIV Research Network (CoRIS). We included ART-naive participants who initiated either bictegravir/emtricitabine/TAF (BIC/FTC/TAF) or dolutegravir + lamivudine (DTG+ 3TC), matched by propensity score, after excluding those with hepatitis B. We compared changes in weight, metabolic biomarkers, and the incidence of metabolism-related clinical events over 96 weeks.
Results
In total, 340 participants were matched in each group. The median age was 34 years, 95% were male, and 62% were from Western Europe. The mean weight gain was 1.4 kg (95% confidence interval [CI]: 1.1, 1.8) after 96 weeks, with no significant differences between the BIC/FTC/TAF and DTG + 3TC groups. Changes in body mass index, lipid levels, hepatic steatosis index, and incidence of clinical events (hypertension, diabetes mellitus, dyslipidemia, and liver steatosis) were also similar between the groups.
Conclusions
In this nationwide cohort of ART-naive individuals, initiation of BIC/FTC/TAF or DTG + 3TC resulted in similar modest increases in weight and lipid levels after 96 weeks, with no significant differences in metabolic outcomes or clinical events. These findings suggest that the metabolic profile of TAF should not be a deciding factor when choosing between 2- and 3-drug ART regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.
- Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
- Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Medicine, Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
ORCID-Profile: Alejandro G García-Ruiz de Morales, Javier Martínez-Sanz
Zitieren
APA
García-Ruiz de Morales, A. G., Suárez Robles, M., Pérez-Elías, M. J., Negredo, E., Alcamí, J., Gómez Rodríguez, C. E., González-Ruano, P., de Zárraga Fernández, M. A., Dueñas Gutiérrez, C., Moreno Guillén, S., & Martínez-Sanz, J. (2025). Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases, 81(2), 263-270. https://doi.org/10.1093/cid/ciae645
Vancouver
García-Ruiz de Morales AG, Suárez Robles M, Pérez-Elías MJ, Negredo E, Alcamí J, Gómez Rodríguez CE, et al. Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. 2025;81(2):263-270. doi:10.1093/cid/ciae645
BibTeX
@article{GarcaRuizdeMorales2025,
author = {García-Ruiz de Morales, Alejandro G and Suárez Robles, Miguel and Pérez-Elías, María Jesús and Negredo, Eugènia and Alcamí, José and Gómez Rodríguez, Carmen Elena and González-Ruano, Patricia and de Zárraga Fernández, Miguel Alberto and Dueñas Gutiérrez, Carlos and Moreno Guillén, Santiago and Martínez-Sanz, Javier},
title = {Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {81},
number = {2},
pages = {263--270},
doi = {10.1093/cid/ciae645}
}
EUVIMED